Chinese General Practice ›› 2022, Vol. 25 ›› Issue (09): 1098-1104.DOI: 10.12114/j.issn.1007-9572.2021.02.074
• Article • Previous Articles Next Articles
Probability of Premature Mortality Caused by Major Non-communicable Diseases in Pudong New Area of Shanghai,2002—2020
Shanghai Pudong New Area Center for Disease Control and Prevention,Fudan University Pudong Institute of Preventive Medicine,Shanghai 200136,China
*Corresponding author:ZHOU Yi,Associate chief physician;E-mail:yizhou517@163.com
Received:
2021-05-28
Revised:
2021-09-28
Published:
2022-03-20
Online:
2022-03-01
通讯作者:
周弋
基金资助:
CLC Number:
CHEN Yichen, CHEN Hua, ZHOU Yi, QU Xiaobing, SUN Lianghong, CHEN Hanyi, LI Xiaopan, YANG Chen, XIAO Shaotan.
Probability of Premature Mortality Caused by Major Non-communicable Diseases in Pudong New Area of Shanghai,2002—2020 [J]. Chinese General Practice, 2022, 25(09): 1098-1104.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.074
时间(年) | 合计 | 男性 | 女性 | |||
---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 526.82 | 404.05 | 567.44 | 475.44 | 486.23 | 345.62 |
2003 | 551.87 | 403.15 | 586.44 | 464.29 | 517.23 | 353.09 |
2004 | 523.01 | 339.30 | 563.07 | 392.09 | 482.77 | 293.35 |
2005 | 561.34 | 353.24 | 609.02 | 411.22 | 513.41 | 302.23 |
2006 | 530.73 | 333.30 | 584.73 | 393.19 | 476.47 | 280.15 |
2007 | 548.57 | 331.27 | 599.47 | 387.71 | 497.50 | 281.17 |
2008 | 562.57 | 321.05 | 605.26 | 369.43 | 519.84 | 277.67 |
2009 | 558.12 | 310.18 | 608.86 | 359.74 | 507.46 | 264.49 |
2010 | 561.81 | 300.35 | 612.74 | 347.76 | 511.05 | 256.12 |
2011 | 584.24 | 303.05 | 641.16 | 351.16 | 527.60 | 257.71 |
2012 | 616.03 | 306.56 | 671.85 | 354.37 | 560.53 | 260.96 |
2013 | 603.96 | 290.88 | 656.52 | 336.60 | 551.69 | 246.28 |
2014 | 621.46 | 288.29 | 680.92 | 333.07 | 562.31 | 244.31 |
2015 | 660.88 | 295.76 | 724.02 | 340.53 | 598.07 | 251.26 |
2016 | 651.72 | 282.50 | 710.19 | 324.48 | 593.56 | 240.32 |
2017 | 660.10 | 277.69 | 718.84 | 317.47 | 601.71 | 237.61 |
2018 | 656.15 | 269.06 | 726.44 | 312.47 | 586.36 | 224.62 |
2019 | 676.91 | 265.75 | 754.59 | 311.23 | 599.91 | 218.96 |
2020 | 678.84 | 260.87 | 741.21 | 299.60 | 617.11 | 220.66 |
合计 | 600.29 | 305.96 | 654.93 | 353.67 | 545.81 | 260.59 |
APC(%) | 1.56 | -2.09 | 1.68 | -2.15 | 1.41 | -2.24 |
Z值 | 13.715 | -12.428 | 16.286 | -12.709 | 10.307 | -12.300 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 The trend analysis of the mortality of four major non-communicable diseases among male and female populations in Pudong New Area of Shanghai,2002—2020
时间(年) | 合计 | 男性 | 女性 | |||
---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 526.82 | 404.05 | 567.44 | 475.44 | 486.23 | 345.62 |
2003 | 551.87 | 403.15 | 586.44 | 464.29 | 517.23 | 353.09 |
2004 | 523.01 | 339.30 | 563.07 | 392.09 | 482.77 | 293.35 |
2005 | 561.34 | 353.24 | 609.02 | 411.22 | 513.41 | 302.23 |
2006 | 530.73 | 333.30 | 584.73 | 393.19 | 476.47 | 280.15 |
2007 | 548.57 | 331.27 | 599.47 | 387.71 | 497.50 | 281.17 |
2008 | 562.57 | 321.05 | 605.26 | 369.43 | 519.84 | 277.67 |
2009 | 558.12 | 310.18 | 608.86 | 359.74 | 507.46 | 264.49 |
2010 | 561.81 | 300.35 | 612.74 | 347.76 | 511.05 | 256.12 |
2011 | 584.24 | 303.05 | 641.16 | 351.16 | 527.60 | 257.71 |
2012 | 616.03 | 306.56 | 671.85 | 354.37 | 560.53 | 260.96 |
2013 | 603.96 | 290.88 | 656.52 | 336.60 | 551.69 | 246.28 |
2014 | 621.46 | 288.29 | 680.92 | 333.07 | 562.31 | 244.31 |
2015 | 660.88 | 295.76 | 724.02 | 340.53 | 598.07 | 251.26 |
2016 | 651.72 | 282.50 | 710.19 | 324.48 | 593.56 | 240.32 |
2017 | 660.10 | 277.69 | 718.84 | 317.47 | 601.71 | 237.61 |
2018 | 656.15 | 269.06 | 726.44 | 312.47 | 586.36 | 224.62 |
2019 | 676.91 | 265.75 | 754.59 | 311.23 | 599.91 | 218.96 |
2020 | 678.84 | 260.87 | 741.21 | 299.60 | 617.11 | 220.66 |
合计 | 600.29 | 305.96 | 654.93 | 353.67 | 545.81 | 260.59 |
APC(%) | 1.56 | -2.09 | 1.68 | -2.15 | 1.41 | -2.24 |
Z值 | 13.715 | -12.428 | 16.286 | -12.709 | 10.307 | -12.300 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
时间(年) | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 210.37 | 156.71 | 202.28 | 163.15 | 19.63 | 14.87 | 94.54 | 69.32 |
2003 | 218.87 | 154.67 | 212.57 | 164.43 | 25.25 | 18.32 | 95.18 | 65.73 |
2004 | 212.37 | 130.90 | 207.28 | 145.36 | 24.65 | 15.79 | 78.71 | 47.26 |
2005 | 233.73 | 139.16 | 217.21 | 148.93 | 25.06 | 15.54 | 85.33 | 49.61 |
2006 | 217.65 | 129.05 | 215.83 | 146.78 | 25.61 | 16.20 | 71.65 | 41.27 |
2007 | 231.19 | 131.37 | 214.61 | 141.81 | 26.06 | 15.70 | 76.71 | 42.40 |
2008 | 243.68 | 129.86 | 215.47 | 136.53 | 25.47 | 14.49 | 77.95 | 40.17 |
2009 | 238.50 | 123.30 | 223.93 | 138.06 | 27.29 | 15.03 | 68.41 | 33.78 |
2010 | 242.66 | 119.41 | 227.19 | 136.13 | 27.33 | 14.41 | 64.63 | 30.40 |
2011 | 249.71 | 118.28 | 234.55 | 137.16 | 29.48 | 15.38 | 70.50 | 32.23 |
2012 | 275.75 | 124.84 | 234.47 | 133.53 | 31.84 | 16.08 | 73.98 | 32.12 |
2013 | 268.57 | 116.60 | 238.02 | 131.08 | 32.93 | 15.97 | 64.44 | 27.23 |
2014 | 279.12 | 117.58 | 238.15 | 127.41 | 34.67 | 15.88 | 69.52 | 27.43 |
2015 | 300.87 | 120.29 | 246.56 | 128.87 | 39.08 | 17.80 | 74.37 | 28.79 |
2016 | 301.54 | 116.97 | 242.73 | 122.80 | 40.16 | 17.62 | 67.29 | 25.10 |
2017 | 304.89 | 113.89 | 244.59 | 121.16 | 44.07 | 18.55 | 66.55 | 24.10 |
2018 | 310.12 | 113.54 | 239.85 | 115.90 | 42.17 | 17.38 | 64.00 | 22.24 |
2019 | 321.27 | 111.44 | 245.51 | 114.32 | 47.05 | 18.60 | 63.08 | 21.38 |
2020 | 335.36 | 114.27 | 246.62 | 112.66 | 45.50 | 17.10 | 51.36 | 16.84 |
合计 | 265.75 | 123.61 | 229.82 | 133.22 | 32.85 | 16.61 | 71.87 | 32.52 |
APC(%) | 22.66 | -1.54 | 1.11 | -1.85 | 4.49 | 0.80 | -2.17 | -6.27 |
Z值 | 20.455 | -8.092 | 13.482 | -17.693 | 16.768 | 2.685 | -6.451 | -16.276 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.016 | <0.001 | <0.001 |
Table 2 The trend analysis of the mortality of four major non-communicable diseases among residents in Pudong New Area of Shanghai,2002—2020
时间(年) | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||
---|---|---|---|---|---|---|---|---|
粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | 粗死亡率 | 标化死亡率 | |
2002 | 210.37 | 156.71 | 202.28 | 163.15 | 19.63 | 14.87 | 94.54 | 69.32 |
2003 | 218.87 | 154.67 | 212.57 | 164.43 | 25.25 | 18.32 | 95.18 | 65.73 |
2004 | 212.37 | 130.90 | 207.28 | 145.36 | 24.65 | 15.79 | 78.71 | 47.26 |
2005 | 233.73 | 139.16 | 217.21 | 148.93 | 25.06 | 15.54 | 85.33 | 49.61 |
2006 | 217.65 | 129.05 | 215.83 | 146.78 | 25.61 | 16.20 | 71.65 | 41.27 |
2007 | 231.19 | 131.37 | 214.61 | 141.81 | 26.06 | 15.70 | 76.71 | 42.40 |
2008 | 243.68 | 129.86 | 215.47 | 136.53 | 25.47 | 14.49 | 77.95 | 40.17 |
2009 | 238.50 | 123.30 | 223.93 | 138.06 | 27.29 | 15.03 | 68.41 | 33.78 |
2010 | 242.66 | 119.41 | 227.19 | 136.13 | 27.33 | 14.41 | 64.63 | 30.40 |
2011 | 249.71 | 118.28 | 234.55 | 137.16 | 29.48 | 15.38 | 70.50 | 32.23 |
2012 | 275.75 | 124.84 | 234.47 | 133.53 | 31.84 | 16.08 | 73.98 | 32.12 |
2013 | 268.57 | 116.60 | 238.02 | 131.08 | 32.93 | 15.97 | 64.44 | 27.23 |
2014 | 279.12 | 117.58 | 238.15 | 127.41 | 34.67 | 15.88 | 69.52 | 27.43 |
2015 | 300.87 | 120.29 | 246.56 | 128.87 | 39.08 | 17.80 | 74.37 | 28.79 |
2016 | 301.54 | 116.97 | 242.73 | 122.80 | 40.16 | 17.62 | 67.29 | 25.10 |
2017 | 304.89 | 113.89 | 244.59 | 121.16 | 44.07 | 18.55 | 66.55 | 24.10 |
2018 | 310.12 | 113.54 | 239.85 | 115.90 | 42.17 | 17.38 | 64.00 | 22.24 |
2019 | 321.27 | 111.44 | 245.51 | 114.32 | 47.05 | 18.60 | 63.08 | 21.38 |
2020 | 335.36 | 114.27 | 246.62 | 112.66 | 45.50 | 17.10 | 51.36 | 16.84 |
合计 | 265.75 | 123.61 | 229.82 | 133.22 | 32.85 | 16.61 | 71.87 | 32.52 |
APC(%) | 22.66 | -1.54 | 1.11 | -1.85 | 4.49 | 0.80 | -2.17 | -6.27 |
Z值 | 20.455 | -8.092 | 13.482 | -17.693 | 16.768 | 2.685 | -6.451 | -16.276 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.016 | <0.001 | <0.001 |
时间(年) | 4类主要慢性病 | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | |
2002 | 13.09 | 16.79 | 9.41 | 3.57 | 4.36 | 2.80 | 8.36 | 11.10 | 5.66 | 0.57 | 0.53 | 0.61 | 1.08 | 1.61 | 0.59 |
2003 | 13.39 | 16.80 | 9.97 | 3.64 | 4.50 | 2.80 | 8.55 | 11.00 | 6.11 | 0.61 | 0.59 | 0.62 | 1.12 | 1.52 | 0.73 |
2004 | 11.66 | 14.66 | 8.59 | 3.10 | 3.87 | 2.34 | 7.59 | 9.71 | 5.44 | 0.57 | 0.55 | 0.57 | 0.78 | 1.13 | 0.45 |
2005 | 11.93 | 15.16 | 8.56 | 3.30 | 4.13 | 2.44 | 7.66 | 9.98 | 5.28 | 0.49 | 0.45 | 0.53 | 0.88 | 1.25 | 0.53 |
2006 | 11.25 | 14.53 | 7.83 | 2.88 | 3.75 | 1.99 | 7.49 | 9.80 | 5.10 | 0.60 | 0.67 | 0.52 | 0.63 | 0.87 | 0.39 |
2007 | 10.76 | 13.91 | 7.46 | 2.91 | 3.92 | 1.88 | 7.00 | 9.08 | 4.84 | 0.47 | 0.47 | 0.47 | 0.70 | 0.98 | 0.42 |
2008 | 10.30 | 12.93 | 7.54 | 2.73 | 3.50 | 1.94 | 6.79 | 8.65 | 4.87 | 0.48 | 0.51 | 0.44 | 0.58 | 0.72 | 0.44 |
2009 | 10.49 | 13.45 | 7.35 | 2.86 | 3.93 | 1.76 | 6.92 | 8.75 | 5.02 | 0.50 | 0.59 | 0.42 | 0.50 | 0.70 | 0.29 |
2010 | 10.06 | 13.04 | 6.91 | 2.60 | 3.42 | 1.75 | 6.83 | 8.93 | 4.63 | 0.48 | 0.51 | 0.45 | 0.42 | 0.63 | 0.20 |
2011 | 9.85 | 12.74 | 6.79 | 2.54 | 3.65 | 1.40 | 6.61 | 8.34 | 4.81 | 0.53 | 0.63 | 0.42 | 0.42 | 0.57 | 0.27 |
2012 | 9.76 | 12.78 | 6.56 | 2.58 | 3.52 | 1.61 | 6.52 | 8.41 | 4.54 | 0.48 | 0.63 | 0.32 | 0.44 | 0.67 | 0.20 |
2013 | 9.55 | 12.69 | 6.25 | 2.46 | 3.49 | 1.40 | 6.39 | 8.31 | 4.40 | 0.45 | 0.57 | 0.33 | 0.49 | 0.77 | 0.21 |
2014 | 9.35 | 12.51 | 6.03 | 2.54 | 3.66 | 1.38 | 6.18 | 8.09 | 4.21 | 0.49 | 0.64 | 0.34 | 0.37 | 0.55 | 0.19 |
2015 | 9.51 | 12.66 | 6.21 | 2.46 | 3.58 | 1.32 | 6.32 | 8.18 | 4.41 | 0.53 | 0.75 | 0.31 | 0.43 | 0.59 | 0.27 |
2016 | 9.23 | 12.21 | 6.11 | 2.44 | 3.47 | 1.38 | 6.13 | 7.96 | 4.24 | 0.57 | 0.74 | 0.41 | 0.31 | 0.45 | 0.18 |
2017 | 8.89 | 11.96 | 5.70 | 2.48 | 3.70 | 1.24 | 5.73 | 7.41 | 4.01 | 0.56 | 0.76 | 0.36 | 0.34 | 0.50 | 0.17 |
2018 | 8.83 | 11.91 | 5.65 | 2.41 | 3.62 | 1.18 | 5.74 | 7.44 | 4.01 | 0.55 | 0.73 | 0.36 | 0.35 | 0.53 | 0.17 |
2019 | 8.47 | 11.61 | 5.25 | 2.33 | 3.46 | 1.19 | 5.51 | 7.31 | 3.68 | 0.55 | 0.76 | 0.34 | 0.28 | 0.47 | 0.10 |
2020 | 8.45 | 11.48 | 5.35 | 2.38 | 3.57 | 1.19 | 5.49 | 7.13 | 3.85 | 0.53 | 0.77 | 0.29 | 0.24 | 0.39 | 0.09 |
合计 | 9.93 | 13.02 | 6.70 | 2.63 | 3.66 | 1.60 | 6.56 | 8.51 | 4.55 | 0.52 | 0.64 | 0.40 | 0.48 | 0.69 | 0.27 |
APC(%) | -2.31 | -1.87 | -3.21 | -2.21 | -1.02 | -4.83 | -2.24 | -2.21 | -2.31 | -0.15 | 2.43 | -3.70 | -7.23 | -6.59 | -9.24 |
Z值 | -15.847 | -11.270 | -20.202 | -9.739 | -4.432 | -15.527 | -19.476 | -15.799 | -15.960 | -0.395 | 5.194 | -8.502 | -13.326 | -10.606 | -11.565 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.698 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 3 The trend analysis of probability of premature mortality caused by four major non-communicable diseases among residents in Pudong New Area of Shanghai,2002—2020
时间(年) | 4类主要慢性病 | 心脑血管疾病 | 恶性肿瘤 | 糖尿病 | 慢性呼吸系统疾病 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | 合计 | 男性 | 女性 | |
2002 | 13.09 | 16.79 | 9.41 | 3.57 | 4.36 | 2.80 | 8.36 | 11.10 | 5.66 | 0.57 | 0.53 | 0.61 | 1.08 | 1.61 | 0.59 |
2003 | 13.39 | 16.80 | 9.97 | 3.64 | 4.50 | 2.80 | 8.55 | 11.00 | 6.11 | 0.61 | 0.59 | 0.62 | 1.12 | 1.52 | 0.73 |
2004 | 11.66 | 14.66 | 8.59 | 3.10 | 3.87 | 2.34 | 7.59 | 9.71 | 5.44 | 0.57 | 0.55 | 0.57 | 0.78 | 1.13 | 0.45 |
2005 | 11.93 | 15.16 | 8.56 | 3.30 | 4.13 | 2.44 | 7.66 | 9.98 | 5.28 | 0.49 | 0.45 | 0.53 | 0.88 | 1.25 | 0.53 |
2006 | 11.25 | 14.53 | 7.83 | 2.88 | 3.75 | 1.99 | 7.49 | 9.80 | 5.10 | 0.60 | 0.67 | 0.52 | 0.63 | 0.87 | 0.39 |
2007 | 10.76 | 13.91 | 7.46 | 2.91 | 3.92 | 1.88 | 7.00 | 9.08 | 4.84 | 0.47 | 0.47 | 0.47 | 0.70 | 0.98 | 0.42 |
2008 | 10.30 | 12.93 | 7.54 | 2.73 | 3.50 | 1.94 | 6.79 | 8.65 | 4.87 | 0.48 | 0.51 | 0.44 | 0.58 | 0.72 | 0.44 |
2009 | 10.49 | 13.45 | 7.35 | 2.86 | 3.93 | 1.76 | 6.92 | 8.75 | 5.02 | 0.50 | 0.59 | 0.42 | 0.50 | 0.70 | 0.29 |
2010 | 10.06 | 13.04 | 6.91 | 2.60 | 3.42 | 1.75 | 6.83 | 8.93 | 4.63 | 0.48 | 0.51 | 0.45 | 0.42 | 0.63 | 0.20 |
2011 | 9.85 | 12.74 | 6.79 | 2.54 | 3.65 | 1.40 | 6.61 | 8.34 | 4.81 | 0.53 | 0.63 | 0.42 | 0.42 | 0.57 | 0.27 |
2012 | 9.76 | 12.78 | 6.56 | 2.58 | 3.52 | 1.61 | 6.52 | 8.41 | 4.54 | 0.48 | 0.63 | 0.32 | 0.44 | 0.67 | 0.20 |
2013 | 9.55 | 12.69 | 6.25 | 2.46 | 3.49 | 1.40 | 6.39 | 8.31 | 4.40 | 0.45 | 0.57 | 0.33 | 0.49 | 0.77 | 0.21 |
2014 | 9.35 | 12.51 | 6.03 | 2.54 | 3.66 | 1.38 | 6.18 | 8.09 | 4.21 | 0.49 | 0.64 | 0.34 | 0.37 | 0.55 | 0.19 |
2015 | 9.51 | 12.66 | 6.21 | 2.46 | 3.58 | 1.32 | 6.32 | 8.18 | 4.41 | 0.53 | 0.75 | 0.31 | 0.43 | 0.59 | 0.27 |
2016 | 9.23 | 12.21 | 6.11 | 2.44 | 3.47 | 1.38 | 6.13 | 7.96 | 4.24 | 0.57 | 0.74 | 0.41 | 0.31 | 0.45 | 0.18 |
2017 | 8.89 | 11.96 | 5.70 | 2.48 | 3.70 | 1.24 | 5.73 | 7.41 | 4.01 | 0.56 | 0.76 | 0.36 | 0.34 | 0.50 | 0.17 |
2018 | 8.83 | 11.91 | 5.65 | 2.41 | 3.62 | 1.18 | 5.74 | 7.44 | 4.01 | 0.55 | 0.73 | 0.36 | 0.35 | 0.53 | 0.17 |
2019 | 8.47 | 11.61 | 5.25 | 2.33 | 3.46 | 1.19 | 5.51 | 7.31 | 3.68 | 0.55 | 0.76 | 0.34 | 0.28 | 0.47 | 0.10 |
2020 | 8.45 | 11.48 | 5.35 | 2.38 | 3.57 | 1.19 | 5.49 | 7.13 | 3.85 | 0.53 | 0.77 | 0.29 | 0.24 | 0.39 | 0.09 |
合计 | 9.93 | 13.02 | 6.70 | 2.63 | 3.66 | 1.60 | 6.56 | 8.51 | 4.55 | 0.52 | 0.64 | 0.40 | 0.48 | 0.69 | 0.27 |
APC(%) | -2.31 | -1.87 | -3.21 | -2.21 | -1.02 | -4.83 | -2.24 | -2.21 | -2.31 | -0.15 | 2.43 | -3.70 | -7.23 | -6.59 | -9.24 |
Z值 | -15.847 | -11.270 | -20.202 | -9.739 | -4.432 | -15.527 | -19.476 | -15.799 | -15.960 | -0.395 | 5.194 | -8.502 | -13.326 | -10.606 | -11.565 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.698 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
类别 | 2015年早死概率 | 2020年早死概率 | 2030年预期早死概率 | 年均增长率 | 2020年目标 | 2030年目标 | |
---|---|---|---|---|---|---|---|
全人群 | 9.51 | 8.45 | 6.67 | -2.33 | 8.56 | 6.66 | |
性别分类 | |||||||
男性 | 12.66 | 11.48 | 9.44 | -1.94 | 11.39 | 8.86 | |
女性 | 6.21 | 5.35 | 3.98 | -2.93 | 5.59 | 4.35 | |
病种分类 | |||||||
心脑血管疾病 | 2.46 | 2.38 | 2.23 | -0.66 | 2.22 | 1.72 | |
恶性肿瘤 | 6.32 | 5.49 | 4.14 | -2.78 | 5.69 | 4.43 | |
糖尿病 | 0.53 | 0.53 | 0.52 | -0.20 | 0.48 | 0.37 | |
慢性呼吸系统疾病 | 0.43 | 0.24 | 0.07 | -11.05 | 0.38 | 0.30 |
Table 4 The analysis ofthetarget in Health China 2030 plan of reducing the probability of premature mortalitycaused by four major non-communicable diseases in Pudong New Area of Shanghai
类别 | 2015年早死概率 | 2020年早死概率 | 2030年预期早死概率 | 年均增长率 | 2020年目标 | 2030年目标 | |
---|---|---|---|---|---|---|---|
全人群 | 9.51 | 8.45 | 6.67 | -2.33 | 8.56 | 6.66 | |
性别分类 | |||||||
男性 | 12.66 | 11.48 | 9.44 | -1.94 | 11.39 | 8.86 | |
女性 | 6.21 | 5.35 | 3.98 | -2.93 | 5.59 | 4.35 | |
病种分类 | |||||||
心脑血管疾病 | 2.46 | 2.38 | 2.23 | -0.66 | 2.22 | 1.72 | |
恶性肿瘤 | 6.32 | 5.49 | 4.14 | -2.78 | 5.69 | 4.43 | |
糖尿病 | 0.53 | 0.53 | 0.52 | -0.20 | 0.48 | 0.37 | |
慢性呼吸系统疾病 | 0.43 | 0.24 | 0.07 | -11.05 | 0.38 | 0.30 |
[1] | World Health Organization. World Health Statistics 2020[EB/OL]. [2021-05-02].. |
[2] | World Health Organization. Global Health Estimates 2016:Deaths by Cause,Age,Sex,by Country and by Region,2000—2016. [EB/OL]. [2021-05-02].. |
[3] | TAN X D,ZHANG Y N,SHAO H Y. Healthy China 2030,a breakthrough for improving health[J]. Glob Health Promot,2019,26(4):96-99. DOI:10.1177/1757975917743533. |
[4] | LUO Z,LV H,CHEN Y C,et al. Years of life lost due to premature death and their trends in people with selected neurological disorders in Shanghai,China,1995—2018:a population-based study[J]. Front Neurol,2021,12:625042. DOI:10.3389/fneur.2021.625042. |
[5] | World Health Organization. Global status report on noncommunicable diseases 2014[M]. Geneva:World Health Organization,2014. |
[6] | 曾新颖,李镒冲,刘世炜,等. 1990—2015年中国四类慢性病早死概率与"健康中国2030"下降目标分析[J]. 中华预防医学杂志,2017,51(3):209-214. DOI:10.3760/cma.j.issn.0253-9624.2017.03.004. |
[7] | ZHOU M G,WANG H D,ZHU J,et al. Cause-specific mortality for 240 causes in China during 1990—2013:a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet,2016,387(10015):251-272. DOI:10.1016/S0140-6736(15)00551-6. |
[8] | 丁贤彬,许杰,焦艳,等. 2015—2019年重庆市主要慢性病早死概率与"健康中国2030"下降目标分析[J]. 中国慢性病预防与控制,2020,28(8):574-577. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.08.005. |
[9] | 杨梨丽,林启,王玉超,等. 2009—2018年舟山市4类主要慢性病早死概率及"健康中国2030"目标分析[J]. 中国慢性病预防与控制,2021,29(2):140-143. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.02.014. |
[10] | 王淼,范美娟. 2006—2019年天津市河西区主要慢性病死亡情况及早死概率趋势分析[J]. 中国慢性病预防与控制,2021,29(1):77-80. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.01.018. |
[11] | 刘天娥,胡永勤,唐爱奇,等. 2010—2018年杭州市余杭区主要慢性病死亡及早死趋势分析[J]. 中国慢性病预防与控制,2020,28(11):878-881. DOI:10.16386/j.cjpccd.issn.1004-6194.2020.11.019. |
[12] | 王联君,周莹,李茜瑶,等. 2007—2018年北京市东城区主要慢性病死亡状况及过早死亡分析[J]. 现代预防医学,2020,47(4):626-630. |
[13] | 朱晓云,张亚宁,马碧萍. 2002—2017年上海市金山区慢性非传染性疾病死亡水平及其所致过早死亡风险分析[J]. 中国预防医学杂志,2019,20(10):966-971. DOI:10.16506/j.1009-6639.2019.10.017. |
[14] | 苏玉,杨益联,徐美娟,等. 2010—2019年天津市东丽区主要慢性病过早死亡趋势分析[J]. 中国慢性病预防与控制,2021,29(3):233-236. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.03.018. |
[15] | 丁贤彬,唐文革,焦艳,等. 2010—2016年重庆市4种主要慢性病早死率及其变化趋势[J]. 中国慢性病预防与控制,2017,25(9):641-645. DOI:10.16386/j.cjpccd.issn.1004-6194.2017.09.001. |
[16] | 国务院办公厅.国务院办公厅关于印发中国防治慢性病中长期规划(2017—2025年)的通知 [EB/OL]. (2017-02-14)[2021-05-02].. |
[17] | 董航,李燕,林国桢,等. 2010—2017年广州市重大慢性非传染性疾病早死概率变化趋势分析[J]. 中国慢性病预防与控制,2019,27(6):472-474. DOI:10.16386/j.cjpccd.issn.1004-6194.2019.06.019. |
[18] | 徐红,黄玮奕. 2005—2018年南通市4类慢性病早死概率及其变化趋势[J]. 中国慢性病预防与控制,2021,29(4):314-317. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.04.018. |
[19] | 王璐,陈海,钱云,等.无锡市2008-2018年主要慢性病过早死亡对期望寿命的影响[J].中华流行病学杂志,2021,42(2):291-296.DOI:10.3760/cma.j.cn112338-20200403-00506. |
[20] | 徐继英,李新建,姚海宏,等. 上海市成年人慢性病相关危险因素行为特征研究[J]. 中华预防医学杂志,2013,47(9):821-825. DOI:10.3760/cma.j.issn.0253-9624.2013.09.011. |
[21] | 王德征,张辉,徐忠良,等.天津市1999—2015年慢性非传染性疾病过早死亡趋势分析[J].中华流行病学杂志,2017,38(12):1672-1676.DOI:10.3760/cma.j.issn.0254-6450.2017.12.018. |
[22] | 邢秀雅,贺琴,程倩瑶,等.安徽省2014—2018年4类重大慢性病早死概率变化趋势及健康指标达标分析[J].中华流行病学杂志,2021,42(3):531-537.DOI:10.3760/cma.j.cn112338-20200319-00391. |
[23] | ZHOU M G,ASTELL-BURT T,BI Y F,et al. Geographical variation in diabetes prevalence and detection in China:multilevel spatial analysis of 98,058 adults[J]. Diabetes Care,2015,38(1):72-81. DOI:10.2337/dc14-1100. |
[24] | RUAN Y,YAN Q H,XU J Y,et al. Epidemiology of diabetes in adults aged 35 and older from Shanghai,China[J]. Biomed Environ Sci,2016,29(6):408-416. DOI:10.3967/bes2016.053. |
[25] | CHEN H Y,HAO L P,YANG C,et al. Understanding the rapid increase in life expectancy in Shanghai,China:a population-based retrospective analysis[J]. BMC Public Health,2018,18(1):256. DOI:10.1186/s12889-018-5112-7. |
[26] | 丁贤彬,唐文革,毛德强,等. 慢性病综合防控示范区建设对主要慢性病早死概率的影响[J]. 中国慢性病预防与控制,2018,26(1):1-4. DOI:10.16386/j.cjpccd.issn.1004-6194.2018.01.001. |
[1] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[2] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[3] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[4] | SHANG Zhonghua, JIANG Zhiyue, HUANG Zhaohui, YANG Xing, LIU Haiyan, ZHANG Li. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035 [J]. Chinese General Practice, 2025, 28(26): 3314-3320. |
[5] | LUO Xinyu, LIU Jin, CHEN Hailong. Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031 [J]. Chinese General Practice, 2025, 28(26): 3321-3327. |
[6] | ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei. Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy [J]. Chinese General Practice, 2025, 28(26): 3307-3313. |
[7] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[8] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[9] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[10] | TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang. Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level [J]. Chinese General Practice, 2025, 28(25): 3096-3103. |
[11] | YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin. Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need" [J]. Chinese General Practice, 2025, 28(25): 3119-3126. |
[12] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[13] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[14] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[15] | WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei. Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(23): 2846-2851. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||